These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4932429)

  • 1. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
    Priori ES; Wilbur JR; Dmochowski L
    J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
    [No Abstract]   [Full Text] [Related]  

  • 2. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
    Holzer G; Kittl E; Pfandelsteiner T; Trieb K; Kotz R
    Med Pediatr Oncol; 2003 Jan; 40(1):64-5. PubMed ID: 12426692
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunofluorescence studies on sera of patients with breast carcinoma.
    Priori ES; Seman G; Dmochowski L; Gallager HS; Anderson DE
    Cancer; 1971 Dec; 28(6):1462-71. PubMed ID: 4108410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological study in carcinogenesis. Distribution of tissue incompatibility antigens (system HL-A) in oncological patients].
    Govallo VI; Shelepina TA
    Vopr Onkol; 1975; 21(9):13-9. PubMed ID: 1059274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Special tumors of childhood].
    Harms D; Schmidt D
    Verh Dtsch Ges Pathol; 1986; 70():190-204. PubMed ID: 3030018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.
    Byers VS; Levin AS; Johnston JO; Hackett AJ
    Cancer Res; 1975 Sep; 35(9):2520-31. PubMed ID: 1097109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
    Donner L; Triche TJ; Israel MA; Seeger RC; Reynolds CP
    Prog Clin Biol Res; 1985; 175():347-66. PubMed ID: 3991736
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 14. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On primary tumors of the ribs].
    Deriu GP; Palladini P; Sartori F; Delbue V; Romani M; Fantin I
    Chir Ital; 1967; ():Suppl 3:1-71. PubMed ID: 4894525
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant, primary bone tumors. Experience report of the Dutch Committee for Bone Tumors].
    von Ronnen JR
    Arch Chir Neerl; 1965; 17(1):23-54. PubMed ID: 5216012
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant jaw tumors in children and adolescence].
    Schilli W; Eschler J
    Dtsch Zahnarztl Z; 1969 Apr; 24(4):280-6. PubMed ID: 4888466
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant bone tumors in the knee region].
    Bumbasirevic Z; Buzdon P
    Beitr Orthop Traumatol; 1984 Feb; 31(2):66-70. PubMed ID: 6586178
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroepidemiology of human sarcoma antigen (S1).
    Hirshaut Y; Pei DT; Marcove RC; Mukherji B; Spielvogel AR; Essner E
    N Engl J Med; 1974 Nov; 291(21):1103-7. PubMed ID: 4608025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.